Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 Clinical research trials and Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 clinical trial. Human subjects often get the best healthcare available for their Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Conditions > Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6



Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

For Condition: Heroin Dependence,Opioid-Related Disorders
Status: Terminated
Sponsor(s): National Institute on Drug Abuse (NIDA) , University of Colorado
Synopsis: to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependenct volunteers
Details: not available at this time
Eligibility:
Study Type:  Interventional, Treatment, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Individuals must be healthy, non-drug dependent volunteers, be at least 18 years of age, and have no prior history of drug or alcohol abuse or dependence. Subjects must have had some minimal experience with opioids (e.g. at least two prior exposures) Exclusion Criteria: Individuals with evidence of an active DSM-IV Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.
Total Enrollment: 0

Location and Contact Information:

Overall Study Official:
LeslieAmass,  Principal Investigator,  University of Colorado

University of Colorado Health Sciences Center
Denver,  Colorado,  80206
United States
 


Additional Information:
Study ID Numbers:  NIDA-11160-6;  R01-11160-6
Study Start Date: 
Record last reviewed: December 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000331

Other Opioid-Related Disorders Studies:
1. Buprenorphine/Naloxone versus Clonidine For Out-patient Opiate Detoxification - 1

2. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3

3. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

4. Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

5. Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Related Studies:

Other Opioid-Related Disorders Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Modify your Search

  Other Opioid-Related Disorders Clinical Trials
  Other Colorado Clinical Trials
  Other Denver Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103